Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant609 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06063746 | Compassionate Use of Vidutolimod | no longer available | — | — | Regeneron PharmaceuticalsINDUSTRY | 0 | Jan 8, 2026 | clinicaltrials |
| NCT04489433 | Compassionate Use Program to Access Trametinib and Dabrafenib for Patients With BRAF Mutation-positive Metastatic Melanoma | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 0 | Dec 18, 2025 | clinicaltrials |
| NCT06590480 | An Expanded Access Program for VO (RP1) in Combination With Nivolumab in Patients With Advanced Melanoma(RPL-EAP-001) | no longer available | — | — | Replimune, Inc.INDUSTRY | 0 | Dec 18, 2025 | clinicaltrials |
| NCT03593499 | Expanded Access to Omaveloxolone for Melanoma for Patients Previously Enrolled in 408-C-1401 | no longer available | — | — | BiogenINDUSTRY | 0 | May 31, 2025 | clinicaltrials |
| NCT04544202 | Compassionate Use Program BRAF Mutation-positive Patients in the Adjuvant Treatment of Melanoma After Surgical Resection | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 0 | Nov 12, 2024 | clinicaltrials |
| NCT04289155 | Individual Patient Compassionate Use of GX-I7 | no longer available | — | — | Genexine, Inc.INDUSTRY | 1 | Mar 17, 2022 | clinicaltrials |
| NCT03554434 | An Expanded Access Program for AM0010 (Pegilodecakin) | no longer available | — | — | Eli Lilly and CompanyINDUSTRY | 0 | Mar 2, 2020 | clinicaltrials |
| NCT02297529 | Expanded Access Study of Talimogene Laherparepvec for Treatment of Subjects With Unresected Stage IIIB-IVM1c Melanoma | no longer available | — | — | AmgenINDUSTRY | 1 | Oct 31, 2019 | clinicaltrials |
| NCT02083484 | Program for Pembrolizumab (MK-3475) in Participants With Metastatic Melanoma Who Have Failed Standard of Care Therapy Including Ipilimumab (MK-3475-030) | no longer available | — | — | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jan 26, 2018 | clinicaltrials |
| NCT03311542 | Expanded Access for Pembrolizumab (MK-3475) | no longer available | — | — | Center Trials & TreatmentOTHER | 4 | Jan 10, 2018 | clinicaltrials |
| NCT02416232 | Access Study of Trametinib for Subjects With Advanced Unresectable (Stage IIIc) or Distant Metastatic (Stage IV) BRAF V600E/K Mutation Positive Cutaneous Melanoma | no longer available | — | — | GlaxoSmithKlineINDUSTRY | 1 | Aug 15, 2017 | clinicaltrials |
| NCT02186249 | Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma(CheckMate218) | no longer available | — | — | Bristol-Myers SquibbINDUSTRY | 2 | Feb 8, 2017 | clinicaltrials |
| NCT02147951 | Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma | no longer available | — | — | AmgenINDUSTRY | 1 | Mar 1, 2016 | clinicaltrials |
| NCT01728051 | Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver | no longer available | — | — | Delcath Systems Inc.INDUSTRY | 1 | Oct 23, 2013 | clinicaltrials |
| NCT00495066 | Compassionate Use Trial for Unresectable Melanoma With Ipilimumab | no longer available | — | — | Bristol-Myers SquibbINDUSTRY | 1 | Jun 3, 2013 | clinicaltrials |
| NCT01005537 | Cyclophosphamide, Autologous Lymphocytes, and Aldesleukin in Treating Patients With Metastatic Melanoma | no longer available | — | — | Fred Hutchinson Cancer CenterOTHER | 0 | Aug 6, 2010 | clinicaltrials |
| NCT00584493 | Treatment Use Study for Advanced Melanoma. | no longer available | — | — | PfizerINDUSTRY | 0 | Dec 14, 2009 | clinicaltrials |
Data updated 22 days agoSource updated Jan 8, 2026source: clinicaltrials